Is TMO or VCYT more undervalued in 2026?

CirclFi compares Thermo Fisher Scientific Inc (TMO) and Veracyte, Inc. (VCYT) using 13 institutional-grade valuation models. TMO has a Quality of Company score of 9.0/10 while VCYT scores 8.8/10.

Which is a better buy — TMO or VCYT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TMO and VCYT valuations compare?

TMO at $487.22 and VCYT at $47.99 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TMO vs VCYT Valuation Comparison 2026 — Intrinsic Value Analysis

TMO

Diagnostics & Research

Thermo Fisher Scientific Inc

Quality

9.0

out of 10

Value Trap

SAFE

Price

$487.22

Last close

Models

12/13

Active

VCYT

Diagnostics & Research

Veracyte, Inc.

Quality

8.8

out of 10

Value Trap

SAFE

Price

$47.99

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	TMO Fair Value	TMO Upside	VCYT Fair Value	VCYT Upside
Bayesian DCF	Intrinsic	$222.35	-54.4%	$27.76	-42.1%
Earnings Power Value	Intrinsic	$28.34	-94.2%	$12.66	-73.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TMO vs VCYT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TMO vs VCYT — Which Stock Is More Undervalued?

TMO scores higher with a 9.0/10 quality rating vs VCYT's 8.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Thermo Fisher Scientific Inc (TMO) and Veracyte, Inc. (VCYT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TMO currently trades at $487.22 with a QOC of 9.0/10, while VCYT trades at $47.99 with a QOC of 8.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).